Matrix metalloproteinase-2 ablation in dystrophin-deficient mdx muscles reduces angiogenesis resulting in impaired growth of regenerated muscle fibers

Human Molecular Genetics

Volumn 20, Issue 9, 2011, Pages 1787-1799

  Miyazaki, Daigo ^a   Nakamura, Akinori ^a   Fukushima, Kazuhiro ^a   Yoshida, Kunihiro ^a   Takeda, Shin'ichi ^b   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b National Institute of Neurology and Psychiatry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DYSTROGLYCAN; BETA SARCOGLYCAN; DYSTROPHIN; DYSTROPHIN ASSOCIATED PROTEIN COMPLEX; GELATINASE A; GELATINASE B; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GROWTH DISORDER; MOUSE; MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SKELETAL MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; DYSTROPHIN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE FIBERS, SKELETAL; MUSCLES; MUSCULAR DYSTROPHY, DUCHENNE; NEOVASCULARIZATION, PATHOLOGIC; REGENERATION;

MUS;

EID: 79954499665     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr062     Document Type: Article

References (57)

1. Emery, A.E. and Gosden, C. (1974) A neurogenic component in muscular dystrophy. J. Med. Genet., 11, 76-79.
2. Hoffmann, E.P., Monaco, A.P., Feener, C.C. and Kunkel, L.M. (1987) Conservation of the Duchenne muscular dystrophy gene in mice and humans. Science, 238, 347-350.
3. Ervasti, J.M. and Campbell, K.P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell, 66, 1121-1131.
4. Ibraghimov-Beskrovnaya, O., Ervasti, M.J., Leveille, J.C., Slaughter, A.C., Sernett, W.S. and Campbell, P.K. (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature, 355, 696-702.
5. Allen, D.G., Whitehead, N.P. and Yeung, E.W. (2005) Mechanisms of stretch-induced muscle damage in normal and dystrophic muscle: role of ionic changes. J. Physiol., 567, 723-735.
6. Mott, J.D. and Werb, Z. (2004) Regulation of matrix biology by matrix metalloproteinases. Curr. Opin. Cell Biol., 16, 558-564.
7. Vu, T.H. and Werb, Z. (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev., 14, 2123-2133.
8. Nagase, H. and Woessner, J.F. Jr (1999) Matrix metalloproteinases. J. Biol. Chem., 274, 21491-21494.
9. Kherif, S., Lafuma, C., Dehaupas, M., Lachkar, S., Fournier, J.G., Verdiere-Sahuque, M., Fardeau, M. and Alameddine, H.S. (1999) Expression of matrix metalloproteinase 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev. Biol., 205, 158-170.
10. Agrawal, S., Anderson, P., Durbeej, M., Rooijen, N., Ivars, F., Opdenakker, G. and Sorokin, L.M. (2006) Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J. Exp. Med., 203, 1007-1019.
11. Zhong, D., Saito, F., Saito, Y., Nakamura, A., Shimizu, T. and Matsumura, K. (2006) Characterization of the protease activity that cleaves the extracellular domain of b-dystroglycan. Biochem. Biophys. Res. Commun., 345, 867-871.
12. Matsumura, K., Zhong, D., Saito, F., Arai, K., Adachi, K., Kawai, H., Higuchi, I., Nishino, I. and Shimizu, T. (2005) Proteolysis of β-dystroglycan in muscular disease. Neuromuscul. Disord., 15, 336-341.
13. Nakamura, A., Yoshida, K., Ueda, H., Takeda, S. and Ikeda, S. (2005) Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise. Biochim. Biophys. Acta, 1740, 326-331.
14. Fukushima, K., Nakamura, A., Ueda, H., Yuasa, K., Yoshida, K., Takeda, S. and Ikeda, S. (2007) Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ). BMC Musculoskelet. Disord., 8, 1-11.
15. Li, H., Mittal, A., Makonchuk, D.Y., Bhatnagar, S. and Kumar, A. (2009) Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. Hum. Mol. Genet., 18, 2584-2598.
16. Chen, X.W., Kuzuya, M., Nakamura, K., Maeda, K., Tsuzuki, M., Kim, W., Sasaki, T., Liu, Z., Inoue, N., Kondo, T. et al. (2007) Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circ. Res., 100, 904-913.
17. Lluri, G. and Jaworski, E.M. (2005) Regulation of TIMP-2, MT1-MMP, and MMP-2 expression during C2C12 differentiation. Muscle Nerve, 32, 492-499.
18. Zimowska, M., Brzoska, E., Swierczynska, M., Streminska, W. and Moraczewski, J. (2008) Distinct patterns of MMP-9 and MMP-2 activity in slow and fast twitch skeletal muscle regeneration in vivo. Int. J. Dev. Biol., 52, 307-314.
19. Itoh, T., Ikeda, T., Gomi, H., Nakao, S., Suzuki, T. and Itohara, S. (1997) Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem., 272, 22389- 22392.
20. Fähling, M., Steege, A., Perlewitz, A., Nafz, B., Mrowka, R., Persson, P.B. and Thiele, B.J. (2005) Role of nucleolin in posttranscriptional control of MMP-9 expression. Biochim. Biophys. Acta, 1731, 32-40.
21. Gillis, J.M. (1999) Understanding dystrophinopathies: an inventory of the structural and functional consequence of the absence of dystrophin in muscles of the mdx mouse. J. Muscle Res. Cell Motil., 20, 605-625.
22. Collen, A., Hanemaaijer, R., Lupu, F., Quax, P.H., van Lent, N., Grimbergen, J., Peters, E., Koolwijk, P. and Hinsbergh, V.W. (2003) Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood, 101, 1810-1817.
23. Silletti, S., Kessler, T., Goldberg, J., Boger, D.L. and Cheresh, D.A. (2001) Disruption of matrix metalloproteinase 2 binding to integrin alpha v beta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc. Natl Acad. Sci. USA, 98, 119-124.
24. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H. and Itohara, S. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res., 58, 1048-1051.
25. Milkiewicz, M., Hudlicka, O., Brown, M.D. and Silgram, H. (2005) Nitric oxide, VEGF and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle. Am. J. Physiol., 289, H336-H343.
26. Reiser, P.J., Kline, W. and Vaghy, P.L. (1997) Induction of neuronal type nitric oxide synthase in skeletal muscle by chronic electrical stimulation in vivo. J. Appl. Physiol., 83, 1250-1255.
27. Hudlicka, O. and Brown, M.D. (2009) Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J. Vasc. Res., 46, 504-512.
28. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K. and Bredt, D.S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell, 82, 743-752.
29. Chang, W.J., Iannaccone, S.T., Lau, K.S., Masters, B.S.S., McCabe, T.J., McMillan, K., Padre, R.C., Spencer, M.J., Tidball, J.G. and Stull, J.T. (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc. Natl Acad. Sci. USA, 93, 9142-9147.
30. Yamada, H., Saito, F., Fukuta-Ohi, H., Zhong, D., Hase, A., Arai, K., Okuyama, A., Maekawa, R., Shimizu, T. and Matsumura, K. (2001) Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum. Mol. Genet., 10, 1563-1569.
31. Bozzi, M., Inzitari, R., Sbardell, D., Monaco, S., Pavoni, E., Gioia, M., Marini, S., Morlacchi, S., Sciandra, F., Castagnola, M. et al. (2009) Enzymatic processing of β-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site. IUBMB Life, 61, 1143-1152.
32. Haas, T.L., Davis, J. and Madri, J.A. (1998) Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem., 273, 3604-3610.
33. Kuzuya, M., Kanda, S., Sasaki, T., Mori, N., Chen, X.W., Itoh, T., Itohara, S. and Iguchi, A. (2003) Deficiency of gelatinase A suppression smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation, 108, 1375-1381.
34. Kinoh, H., Sato, H., Tsunezuka, Y., Takino, T., Kawashima, A., Okada, Y. and Seiki, M. (1996) MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J. Cell. Sci., 109, 953-959.
35. Matsumoto, T. and Claesson-Welsh, L. (2001) VEGF receptor signal transduction. Sci. STKE, 112, 1-17.
36. Germani, A., Carlo, A.D., Mangori, A., Straino, S., Giacinti, C., Turrini, P., Biglioli, P. and Capogrossi, C. (2003) Vascular endothelial growth factor modulates skeletal myoblast function. Am. J. Pathol., 163, 1417-1428.
37. Messina, S., Mazzeo, A., Bitto, A., Aguennouz, M., Migliorato, A., Pasquale, M.G., Minutoli, L., Altavilla, D., Zentilin, L., Giacca, M., Squandrito, F. and Vita, G. (2007) VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice. FASEB J., 21, 3737-3746.
38. Arsic, N., Zacchigna, S., Zentilin, L., Ramirez-Correa, G., Pattarini, L., Salvi, A., Sinagra, G. and Giacca, M. (2004) Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol. Ther., 10, 844-854.
39. De Angelis, L., Berghella, L., Coletta, M., Lattanzi, L., Zanchi, M., Cusela-De Angelis, M.G., Ponzetto, C. and Cossu, G. (1999) Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J. Cell Biol., 147, 869-877.
40. Chetty, C., Lakka, S.S., Bhoopathi, P. and Rao, J. (2009) MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells. Int. J. Cancer, 127, 1081-1095.
41. Heizmann, C.W., Fritz, G. and Schafer, B.W. (2002) S100 proteins: structure, functions and pathology. Front. Biosci., 7, d1356-d1368.
42. Yong, H.Y. and Moon, A. (2007) Role of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res., 30, 75-81.
43. van Lent, P.L., Grevers, L.C., Blom, A.B., Arntz, O.J., van de Loo, F.A., van der Kraan, P., Abdollahi-Roodsaz, S., Srikrishna, G., Freeze, H., Sloetjes, A. et al. (2008) Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum., 58, 3776-3787.
44. Lloyd, P.G., Yang, H.T. and Terjung, R.L. (2001) Arteriogenesis and angiogenesis in rat ischemic hindlimb: role of nitric oxide. Am. J. Physiol. Heart Circ. Physiol., 281, H2528-H2538.
45. Wehling, M., Spencer, M.J. and Tidball, J.G. (2001) A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J. Cell Biol., 155, 123-131.
46. Ito, K., Kimura, S., Ozasa, S., Matsukura, M., Ikezawa, M., Yoshioka, K., Ueno, H., Suzuki, M., Araki, K., Yamamura, K. et al. (2006) Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Hum. Mol. Genet., 15, 2266-2275.
47. Guggilam, A., Patel, K.P., Haque, M., Ebenezer, P.J., Kapusta, D.R. and Francis, J. (2008) Cytokine blockade attenuates sympathoexcitation in heart failure: cross-talk between nNOS, AT-1R and cytokines in the hypothalamic paraventricular nucleus. Eur. J. Heart Fail., 10, 625-634.
48. Ehlermann, P., Eggers, K., Bierhaus, A., Most, P., Weichenhan, D., Greten, J., Nawroth, P.P., Katus, H.A. and Remppis, A. (2006) Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc. Diabetol., 5,6.
49. Lange, M., Nakano, Y., Traber, D.L., Hamahata, A., Esechie, A., Jonkam, C., Bansal, K., Traber, L.D. and Enkhbaatar, P. (2010) Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem. Biophys. Res. Commun., 399, 286-291.
50. Gebhardt, C., Nemeth, J., Angel, P. and Hess, J. (2006) S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol., 72, 1622-1631.
51. Nauck, M., Karakiulakis, G., Perruchoud, A.P., Papakonstaninou, E. and Roth, M. (1998) Corticosteroid inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur. J. Pharmacol., 341, 309-315.
52. Pross, C., Farooq, M.M., Angle, N., Lane, J.S., Cerveira, J.J., Xavier, A.E., Freischlag, J.A., Law, R.E. and Gelabert, H.A. (2002) Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. J. Surg. Res., 102, 57-62.
53. Menezes, L.G., Sobreira, C., Neder, L., Rodrigeus, A.L. Jr and Martinez, J.A.B. (2007) Creatine supplementation attenuates corticosteroid-induced muscle wasting and impairment of exercise performance in rats. J. Appl. Physiol., 102, 698-703.
54. Barel, M., Perez, O.A.B., Giozzet, V.A., Rafacho, A., Bosqueiro, J.R. and Amaral, S.L. (2010) Exercise training prevents hyperinsulinemia, muscular glycogen loss and muscle atrophy induced by dexamethasone treatment. Eur. J. Appl. Physiol., 108, 999-1007.
55. Amalfitano, A. and Chamberlain, J.S. (1996) The mdx-amplification- resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve, 19, 1549-1553.
56. Massa, R., Silvestri, G., Zeng, Y.C., Martorana, A., Sancesario, G. and Bernardi, G. (1997) Muscle regeneration in mdx mice: resistance to repeated necrosis is compatible with myofiber maturity. Basic Appl. Myol., 7, 387-394.
57. Gosselin, L.E., Williams, J.E., Personius, K. and Farkas, G.A. (2007) A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone. Muscle Nerve, 35, 208-216.